MedTrace Logo

Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis

NCT01903213 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 123

Last updated 2024-10-22

No results posted yet for this study

Summary

To evaluate the safety and efficacy of long-term use of Kiklin® Capsules in actual clinical settings.

Conditions

  • Chronic Renal Failure

Interventions

DRUG

bixalomer

Oral

Sponsors & Collaborators

  • Astellas Pharma Inc

    lead INDUSTRY

Principal Investigators

  • Use Central Contact · Astellas Pharma Inc

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-19
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01903213 on ClinicalTrials.gov